1. Disease Management: High Risk Groups Principles in Practice Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 1

2. 7 Studies that attempt to identify, measure, and evaluate the end results of health care services. This necessitates consideration of clinical, economic, and humanistic outcomes to obtain a complete evaluation of the quality of health care. Click here and overtype for title Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 2 Outcomes Research

3. A process of reviewing a group of individuals in a geographic area or in a particular health plan/environment for desired characteristics. Click here and overtype for title Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 3 Population Stratification

4. The description and analysis of the costs and consequences of pharmaceuticals and pharmaceutical services and their impact on individuals, health care systems, and society. Pharmacoeconomics is a division of outcomes research and generally addresses both economic and humanistic outcomes. Click here and overtype for title Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 4 Pharmacoeconomics

5. The viewpoint from which an outcomes analysis is performed –Society –Payers –Providers –Patients Click here and overtype for title Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 5 Outcomes Perspective

6. A model organizing outcomes of health care along three general dimensions: –Economic Outcomes Direct, indirect, and tangible costs compared with the consequences of health care treatment alternatives –Clinical Outcomes Health care events that occur as a result of disease or treatment –Humanistic Outcomes Consequences of disease or treatment on patient functional status or quality of life measured along several dimensions, e.g., physical functioning, social functioning, general health perceptions and well- being Click here and overtype for title Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 6 ECHO Model

7. The process of assigning or segmenting a patient population relative to a specific research question into levels of severity of disease, levels of desired characteristics or levels of resource consumption. Click here and overtype for title Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 7 Risk Stratification

8. An analytical technique that enumerates and compares the net costs of a healthcare intervention with the net benefits, or cost savings, that arise as a consequence of applying that intervention. Results of both the costs and the health outcomes are expressed entirely in monetary units. Click here and overtype for title Copyright © 2002-2005 – Academy of Managed Care Pharmacy (AMCP)Slide 8 Cost-Benefit Analysis